Skip to main content

Table S1 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T

Publication ,  Other
Brown, MC; D’Anniballe, VM; Boczkowski, D; Kandadi, H; Sheikh, N; Kornahrens, W; Heath, EI; Thakur, A; Chen, W; Lum, L; Cackowski, FC ...
October 18, 2024

<p>Clinical cohort characteristics</p>

Duke Scholars

DOI

Publication Date

October 18, 2024
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brown, M. C., D’Anniballe, V. M., Boczkowski, D., Kandadi, H., Sheikh, N., Kornahrens, W., … Nair, S. K. (2024). Table S1 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T. https://doi.org/10.1158/2767-9764.27255825
Brown, Michael C., Vincent M. D’Anniballe, David Boczkowski, Harini Kandadi, Nadeem Sheikh, William Kornahrens, Elisabeth I. Heath, et al. “Table S1 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T,” October 18, 2024. https://doi.org/10.1158/2767-9764.27255825.
Brown MC, D’Anniballe VM, Boczkowski D, Kandadi H, Sheikh N, Kornahrens W, Heath EI, Thakur A, Chen W, Lum L, Cackowski FC, Boerner J, Gunn MD, Armstrong AJ, Nair SK. Table S1 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T. 2024.

DOI

Publication Date

October 18, 2024